AlphaGrep UK’s Teladoc Health TDOC Stock Holding History

AlphaGrep UK’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,209	Closed	-$82.9K	–	949
2026 Q1	$82.9K	Buy	+15,209	New	+$85.3K	0.02%	755

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AlphaGrep UK's TDOC Position: Q2 2026 in Review

AlphaGrep UK sold out of Teladoc Health (TDOC) in Q2 2026, closing a stake of 15,209 shares — an estimated $82.9K sold.

AlphaGrep UK first reported a position in TDOC in Q1 2026 and held it in 1 quarter. The position peaked at $82.9K in Q1 2026. 326 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

AlphaGrep UK reported no remaining Teladoc Health position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 15,209 Teladoc Health shares in Q2 2026, an estimated $82.9K.
AlphaGrep UK first reported a position in Teladoc Health in Q1 2026 and held it in 1 quarter.
AlphaGrep UK's Teladoc Health position peaked at $82.9K in Q1 2026.
326 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.